Status:
UNKNOWN
Influence of Co-diagnosis of Chronic Fatigue Syndrome in Patients With Fibromyalgia.
Lead Sponsor:
University of Extremadura
Conditions:
Fibromyalgia
Chronic Fatigue Syndrome
Eligibility:
FEMALE
40-65 years
Brief Summary
The purpose of this study is to evaluate differences in neuroimmunoendocrine response and quality of live in patients diagnosed with Fibromyalgia, with or without a co-diagnosis of Chronic Fatigue Syn...
Detailed Description
The limited literature published in concordant relation affects the chronic fatigue syndrome comorbidity in the daily life of fibromyalgia patients leads us to design this study with the main objectiv...
Eligibility Criteria
Inclusion
- Fibromyalgia and/or Chronic Fatigue Syndrome diagnosis by rheumatologists or internal medicine professionals.
- Age not less than 40 years old and not more than 65 years old.
Exclusion
- Suffering from diagnosed "major depression".
- Suffer diagnosed multiple chemical sensitivity.
- Corticosteroid treatment or anti-cytokine therapies.
- Periodically carry out programmed therapeutic physical activity in the two months prior to the accelerometry tests.
Key Trial Info
Start Date :
June 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 16 2024
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05323838
Start Date
June 9 2021
End Date
November 16 2024
Last Update
May 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Extremadura
Badajoz, Spain, 06006